Sabic said it has signed a letter of intent with Japan's Mitsubishi Rayon to set up a joint venture with an estimated cost of $1 billion. The plant would produce 250,000 tons per year of methyl methacrylate monomers and is expected to start production in 2013, Sabic said in a statement.
How AI and Robotics are reshaping the race for materials discovery.
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
Incredible but true: CHEManager International is celebrating its 20th anniversary!
Part 1: Building a Business Case for Pharma 4.0
Trump's tariff policy is a considerable burden and a break with previous practice.
